HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation

Ernest T. Chivero, Minglei Guo, Palsamy Periyasamy, Ke Liao, Shannon E. Callen, Shilpa J Buch

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Neuroinflammation associated with HIV-1 infection is a problem affecting <50% of HIV-infected individuals. NLR family pyrin domain containing 3 (NLRP3) inflammasome has been implicated in HIV-induced microglial activation, but the mechanism(s) remain unclear. Because HIV-1 Transactivator of Transcription (Tat) protein continues to be present despite antiretroviral therapy and activates NF-kB, we hypothesized that Tat could prime the NLRP3 inflammasome. We found a dose- and time-dependent induction of NLRP3 expression in microglia exposed to Tat compared with control. Tat exposure also time-dependently increased the mature caspase-1 and IL-1β levels and enhanced the IL-1β secretion. These in vitro findings were validated in archival brain tissues from Simian Immunodeficiency Virus (SIV)-infected and uninfected rhesus macaques. Further validation of NLRP3 priming in vivo involved administration of lipopolysac-charide (LPS) to HIV transgenic (Tg) rats followed by assessment of IL-1β mRNA expression and inflammasome activation (ASC oligomers and mature IL-1β). Intriguingly, LPS potentiated upregulation of IL-1β mRNA and inflammasome activation in HIV-Tg rats compared with the wild-type controls. Interestingly, we found an inverse relationship in the expression of NLRP3 and its negative regulator, miR-223, suggesting a miR-223-mediated mechanism for Tat-induced NLRP3 priming. Furthermore, blockade of NLRP3 resulted in decreased IL-1β secretion. Collectively, these findings suggest a novel role of Tat in priming and activating the NLRP3 inflammasome. Therefore, NLRP3 can be envisioned as a therapeutic target for ameliorating Tat-mediated neuroinflammation.

Original languageEnglish (US)
Pages (from-to)3599-3609
Number of pages11
JournalJournal of Neuroscience
Volume37
Issue number13
DOIs
StatePublished - Mar 29 2017

Fingerprint

Inflammasomes
Trans-Activators
HIV-1
Interleukin-1
HIV
Transgenic Rats
Caspase 1
Simian Immunodeficiency Virus
Messenger RNA
NF-kappa B
Microglia
Macaca mulatta
HIV Infections
Up-Regulation
Brain
Therapeutics

Keywords

  • HIV-1 Tat
  • Inflammasome
  • Microglia
  • NLRP3
  • Neuroinflammation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation. / Chivero, Ernest T.; Guo, Minglei; Periyasamy, Palsamy; Liao, Ke; Callen, Shannon E.; Buch, Shilpa J.

In: Journal of Neuroscience, Vol. 37, No. 13, 29.03.2017, p. 3599-3609.

Research output: Contribution to journalArticle

Chivero, Ernest T. ; Guo, Minglei ; Periyasamy, Palsamy ; Liao, Ke ; Callen, Shannon E. ; Buch, Shilpa J. / HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation. In: Journal of Neuroscience. 2017 ; Vol. 37, No. 13. pp. 3599-3609.
@article{376f8732f94a4b2c92489445e4ef492a,
title = "HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation",
abstract = "Neuroinflammation associated with HIV-1 infection is a problem affecting <50{\%} of HIV-infected individuals. NLR family pyrin domain containing 3 (NLRP3) inflammasome has been implicated in HIV-induced microglial activation, but the mechanism(s) remain unclear. Because HIV-1 Transactivator of Transcription (Tat) protein continues to be present despite antiretroviral therapy and activates NF-kB, we hypothesized that Tat could prime the NLRP3 inflammasome. We found a dose- and time-dependent induction of NLRP3 expression in microglia exposed to Tat compared with control. Tat exposure also time-dependently increased the mature caspase-1 and IL-1β levels and enhanced the IL-1β secretion. These in vitro findings were validated in archival brain tissues from Simian Immunodeficiency Virus (SIV)-infected and uninfected rhesus macaques. Further validation of NLRP3 priming in vivo involved administration of lipopolysac-charide (LPS) to HIV transgenic (Tg) rats followed by assessment of IL-1β mRNA expression and inflammasome activation (ASC oligomers and mature IL-1β). Intriguingly, LPS potentiated upregulation of IL-1β mRNA and inflammasome activation in HIV-Tg rats compared with the wild-type controls. Interestingly, we found an inverse relationship in the expression of NLRP3 and its negative regulator, miR-223, suggesting a miR-223-mediated mechanism for Tat-induced NLRP3 priming. Furthermore, blockade of NLRP3 resulted in decreased IL-1β secretion. Collectively, these findings suggest a novel role of Tat in priming and activating the NLRP3 inflammasome. Therefore, NLRP3 can be envisioned as a therapeutic target for ameliorating Tat-mediated neuroinflammation.",
keywords = "HIV-1 Tat, Inflammasome, Microglia, NLRP3, Neuroinflammation",
author = "Chivero, {Ernest T.} and Minglei Guo and Palsamy Periyasamy and Ke Liao and Callen, {Shannon E.} and Buch, {Shilpa J}",
year = "2017",
month = "3",
day = "29",
doi = "10.1523/JNEUROSCI.3045-16.2017",
language = "English (US)",
volume = "37",
pages = "3599--3609",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "13",

}

TY - JOUR

T1 - HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation

AU - Chivero, Ernest T.

AU - Guo, Minglei

AU - Periyasamy, Palsamy

AU - Liao, Ke

AU - Callen, Shannon E.

AU - Buch, Shilpa J

PY - 2017/3/29

Y1 - 2017/3/29

N2 - Neuroinflammation associated with HIV-1 infection is a problem affecting <50% of HIV-infected individuals. NLR family pyrin domain containing 3 (NLRP3) inflammasome has been implicated in HIV-induced microglial activation, but the mechanism(s) remain unclear. Because HIV-1 Transactivator of Transcription (Tat) protein continues to be present despite antiretroviral therapy and activates NF-kB, we hypothesized that Tat could prime the NLRP3 inflammasome. We found a dose- and time-dependent induction of NLRP3 expression in microglia exposed to Tat compared with control. Tat exposure also time-dependently increased the mature caspase-1 and IL-1β levels and enhanced the IL-1β secretion. These in vitro findings were validated in archival brain tissues from Simian Immunodeficiency Virus (SIV)-infected and uninfected rhesus macaques. Further validation of NLRP3 priming in vivo involved administration of lipopolysac-charide (LPS) to HIV transgenic (Tg) rats followed by assessment of IL-1β mRNA expression and inflammasome activation (ASC oligomers and mature IL-1β). Intriguingly, LPS potentiated upregulation of IL-1β mRNA and inflammasome activation in HIV-Tg rats compared with the wild-type controls. Interestingly, we found an inverse relationship in the expression of NLRP3 and its negative regulator, miR-223, suggesting a miR-223-mediated mechanism for Tat-induced NLRP3 priming. Furthermore, blockade of NLRP3 resulted in decreased IL-1β secretion. Collectively, these findings suggest a novel role of Tat in priming and activating the NLRP3 inflammasome. Therefore, NLRP3 can be envisioned as a therapeutic target for ameliorating Tat-mediated neuroinflammation.

AB - Neuroinflammation associated with HIV-1 infection is a problem affecting <50% of HIV-infected individuals. NLR family pyrin domain containing 3 (NLRP3) inflammasome has been implicated in HIV-induced microglial activation, but the mechanism(s) remain unclear. Because HIV-1 Transactivator of Transcription (Tat) protein continues to be present despite antiretroviral therapy and activates NF-kB, we hypothesized that Tat could prime the NLRP3 inflammasome. We found a dose- and time-dependent induction of NLRP3 expression in microglia exposed to Tat compared with control. Tat exposure also time-dependently increased the mature caspase-1 and IL-1β levels and enhanced the IL-1β secretion. These in vitro findings were validated in archival brain tissues from Simian Immunodeficiency Virus (SIV)-infected and uninfected rhesus macaques. Further validation of NLRP3 priming in vivo involved administration of lipopolysac-charide (LPS) to HIV transgenic (Tg) rats followed by assessment of IL-1β mRNA expression and inflammasome activation (ASC oligomers and mature IL-1β). Intriguingly, LPS potentiated upregulation of IL-1β mRNA and inflammasome activation in HIV-Tg rats compared with the wild-type controls. Interestingly, we found an inverse relationship in the expression of NLRP3 and its negative regulator, miR-223, suggesting a miR-223-mediated mechanism for Tat-induced NLRP3 priming. Furthermore, blockade of NLRP3 resulted in decreased IL-1β secretion. Collectively, these findings suggest a novel role of Tat in priming and activating the NLRP3 inflammasome. Therefore, NLRP3 can be envisioned as a therapeutic target for ameliorating Tat-mediated neuroinflammation.

KW - HIV-1 Tat

KW - Inflammasome

KW - Microglia

KW - NLRP3

KW - Neuroinflammation

UR - http://www.scopus.com/inward/record.url?scp=85016486822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016486822&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3045-16.2017

DO - 10.1523/JNEUROSCI.3045-16.2017

M3 - Article

C2 - 28270571

AN - SCOPUS:85016486822

VL - 37

SP - 3599

EP - 3609

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 13

ER -